Large-scale expansion of CD3+CD56+ lymphocytes capable of lysing autologous tumor cells with cytokine-rich supernatants

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2002-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-002-0298-yPMID 12202905PMCID PMC11034174
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Loss of IFN-γ Production by Invariant NK T Cells in Advanced Cancer1

  2001cited by this paper
• Interleukin 15: biology and relevance to human disease.

  2001cited by this paper
• Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function

  2000cited by this paper
• Compromised anti‐tumor responses in tumor necrosis factor‐α knockout mice

  2000cited by this paper
• Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor

  2000cited by this paper
• IL-18 up-regulates perforin-mediated NK activity without increasing perforin messenger RNA expression by binding to constitutively expressed IL-18 receptor.

  1999cited by this paper
• Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas.

  1999cited by this paper
• Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin α

  1999cited by this paper
• A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.

  1998cited by this paper
• Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.

  1998cited by this paper
• NK cell receptors.

  1998cited by this paper
• Arousal and inhibition of human NK cells

  1997cited by this paper
• Protein sorting and secretion during CTL killing.

  1997cited by this paper
• Induction of anti-tumour lymphocytes in cancer patients after brief exposure to supernatants from cultures of anti-CD3-stimulated allogeneic lymphocytes.

  1997cited by this paper
• Activated T cells and cytokine-induced CD3+CD56+ killer cells

  1997cited by this paper
• High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2.

  1996influential reference
• Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo.

  1996cited by this paper
• Interleukin 15 induction of lymphokine-activated killer cell function against autologous tumor cells in melanoma patient lymphocytes by a CD18-dependent, perforin-related mechanism.

  1995influential reference
• Characterization of the anti-tumor immune response in human cancers and strategies for immunotherapy.

  1994cited by this paper
• Lysis of neuroblastoma cell lines by human natural killer cells activated by interleukin-2 and interleukin-12.

  1994influential reference
• Interleukin 1 beta synergises with interleukin 2 in the outgrowth of autologous tumour-reactive CD8+ effectors.

  1994cited by this paper
• A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency.

  1994influential reference
• Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer

  1994cited by this paper
• Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.

  1993cited by this paper
• Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice.

  1993cited by this paper
• Multiple defects of immune cell function in mice with disrupted interferon-gamma genes.

  1993cited by this paper
• Elevated prostaglandin E2 production by monocytes is responsible for the depressed levels of natural killer and lymphokine‐activated killer cell function in patients with breast cancer

  1993cited by this paper
• Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.

  1991cited by this paper
• Immunotherapy and gene therapy of cancer.

  1991cited by this paper
• Role of CD18 in lymphokine, activated killer (LAK) cell‐mediated lysis of human monocytes: Comparison with other lak targets

  1990cited by this paper
• Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells

  1990influential reference
• Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

  1986cited by this paper
• The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

  1986cited by this paper
• A subset of natural killer cells in peripheral blood displays a mature T cell phenotype

  1986cited by this paper
• Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.

  1984cited by this paper

• A review and statistical analysis to identify and describe relationships between CQAs and CPPs of natural killer cell expansion processes.

  2024cites this paper
• Patient-Derived In Vitro Models of Ovarian Cancer: Powerful Tools to Explore the Biology of the Disease and Develop Personalized Treatments

  2023cites this paper
• Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer

  2020cites this paper
• The Efficacy of CIK-Based Immunotherapies for Advanced Solid Tumors

  2017cites this paper
• Adoptive immunotherapy against ovarian cancer

  2016cites this paper
• A Cytokine Cocktail Augments the Efficacy of Adoptive NK-92 Cell Therapy Against Mouse Xenografts of Human Cancer.

  2016cites this paper
• The tumor antigen N-glycolyl-GM3 is a human CD1d ligand capable of mediating B cell and natural killer T cell interaction

  2016cites this paper
• Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma.

  2015cites this paper
• Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

  2015cites this paper
• Adoptive T cell therapy combined with intralesional administrations of TG1042 (adenovirus expressing interferon-γ) in metastatic melanoma patients

  2015cites this paper
• Biological activity of cytotoxic dendritic cells cocultured with cytokine-induced killer cells and their effect on acute leukemia cells.

  2015cites this paper
• Maintenance Therapy With Autologous Cytokine-induced Killer Cells in Patients With Advanced Epithelial Ovarian Cancer After First-line Treatment

  2014cites this paper
• Clinical evaluation of autologous DC and CIK cell therapy combine with chemotherapy in lung cancer patients

  2014cites this paper
• Up-regulation of DNAM-1 and NKp30, associated with improvement of NK cells activation after long-term culture of mononuclear cells from patients with ovarian neoplasia.

  2014cites this paper
• Modulation of peripheral immune responses by paclitaxel–ifosfamide–cisplatin chemotherapy in advanced non-small-cell lung cancer

  2013cites this paper
• Immunotherapy with Cytokine-Induced Killer Cells as an Adjuvant Treatment for Advanced Gastric Carcinoma: A Retrospective Study of 165 Patients

  2013cites this paper
• CD3+CD56+natural killer T cells in fibromyalgia syndrome patients: association with the intensity of depression.

  2013cites this paper
• Chemotherapy ± Cetuximab Modulates Peripheral Immune Responses in Metastatic Colorectal Cancer

  2013cites this paper
• A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocelluar carcinoma

  2013cites this paper
• Numbers and cytotoxicities of CD3+CD56+ T lymphocytes in peripheral blood of patients with acute myeloid leukemia and acute lymphocytic leukemia

  2013cites this paper
• Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells

  2013cites this paper
• Combined treatment with Bevacizumab and standard chemotherapy restores abnormal immune parameters in advanced colorectal cancer patients

  2012cites this paper
• Autologous Cytokine-induced Killer Cell Transfusion in Combination With Gemcitabine Plus Cisplatin Regimen Chemotherapy for Metastatic Nasopharyngeal Carcinoma

  2012cites this paper
• Characterization and Comparison of ‘Standard’ and ‘Young’ Tumour‐Infiltrating Lymphocytes for Adoptive Cell Therapy at a Danish Translational Research Institution

  2012cites this paper
• Increased numbers but functional defects of CD 56 1 CD 3 1 cells in lung cancer

  2012cites this paper
• Increased numbers but functional defects of CD56+CD3+ cells in lung cancer.

  2012cites this paper
• Ex vivo Expansion of CD56+ NK and NKT‐like Lymphocytes from Peripheral Blood Mononuclear Cells of Patients with Ovarian Neoplasia

  2011cites this paper
• Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients.

  2010cites this paper
• A clinical trial of cytokine induced killer cells treating patients with malignant tumor after radiochemotherapy

  2010cites this paper
• Expression of adhesion molecules and ligands for activating and costimulatory receptors involved in cell-mediated cytotoxicity in a large panel of human melanoma cell lines

  2009cites this paper
• Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge

  2009cites this paper
• Positive psychosocial factors and NKT cells in ovarian cancer patients.

  2008influential citation
• Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas

  2008cites this paper
• The expression of HLA class I molecules and complement regulatory proteins in ovarian cancer

  2008cites this paper
• Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells.

  2008cites this paper
• Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group

  2005cites this paper
• Natural killer cell-based immunotherapeutic strategies.

  2005cites this paper
• CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype

  2005cites this paper
• Ex vivo Expansion of Highly Purified NK Cells for Immunotherapy after Haploidentical Stem Cell Transplantation in Children

  2005cites this paper
• Variations in alveolar cell populations, lymphocyte subsets and NK-cells in different stages of active pulmonary sarcoidosis.

  2005cites this paper
• Ex vivo expansion of natural killer cells for clinical applications.

  2004cites this paper
• Expression of NK-associated receptors on cytotoxic T cells from melanoma patients: a two-edged sword?

  2004cites this paper
• Polysaccharides of Ganoderma lucidum alter cell immunophenotypic expression and enhance CD56+ NK-cell cytotoxicity in cord blood.

  2004cites this paper
• IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.

  2004cites this paper
• Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma

  2004cites this paper
• Phenotypic and Functional Characterization of Long-Term Cultured Rhesus Macaque Spleen-Derived NKT Cells 1

  2003cites this paper
• Spleen-Derived NKT Cells of Long-Term Cultured Rhesus Macaque Phenotypic and Functional Characterization

  2003cites this paper
• Transfer of TCR Genes into Mature T Cells Is Accompanied by the Maintenance of Parental T Cell Avidity

  2003cites this paper
• Parental T Cell Avidity Is Accompanied by the Maintenance of Transfer of TCR Genes into Mature T Cells

  2003cites this paper